Definitely a good opportunity to top up considering the expected...

Definitely a good opportunity to top up considering the expected news flow within this and early next quarter imo..

1. ARDS - Update
" Pre-IND meeting with the FDA regarding clinical trial development program"

"Camargo will report these results to FDA in a comprehensive information package which will also outline future clinical development plans for IHL-675A"

+ further information on proceedings with new conditions

"" IBD , COPD, asthma and bronchitis

• Incannex will now expand its discussions with research organisations and regulators to continue a

clinical and regulatory strategy and these negotiations are ongoing. ""

work your magic Camargo!!

2. Further information re the psychedelics program and trial #2

3. An update re-OSA

4. An update re dual listing considering Eddie sugars options have been sorted